Needham & Company LLC Reaffirms Hold Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

DENTSPLY SIRONA (NASDAQ:XRAY)‘s stock had its “hold” rating reaffirmed by Needham & Company LLC in a report released on Thursday, MarketBeat reports.

A number of other research firms also recently commented on XRAY. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and cut their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating for the company in a report on Tuesday, December 17th. Finally, Evercore ISI reaffirmed an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Twelve analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus target price of $23.58.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $15.33 on Thursday. The company’s fifty day moving average price is $18.35 and its two-hundred day moving average price is $20.97. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market capitalization of $3.05 billion, a P/E ratio of -7.41, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a 12 month low of $15.30 and a 12 month high of $34.28.

Insider Buying and Selling

In other news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were acquired at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.52% of the stock is owned by insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently modified their holdings of the company. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at $26,000. Colonial Trust Co SC bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter worth about $26,000. MassMutual Private Wealth & Trust FSB increased its position in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. grew its stake in DENTSPLY SIRONA by 60.8% in the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after purchasing an additional 564 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 1,568 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.